On June 7, 2023, the European Commission might propose a modification of the regulatory framework for GMOs. Its goal is to have GMO obtained by “directed mutagenesis and cisgenesis” excluded from the requirements of labelling and risk assessment, which would concern only transgenic GMOs. But, according to the European experts, the very notion of “transgenic” could also be modified in order to further restrict the number of GMOs concerned by, among other things, this risk assessment and labelling.
Three-parent in vitro fertilisation (IVF), which came out of the laboratories in 2015, is intended to solve certain hereditary diseases. Sometimes referred to as “mitochondrial donation”, this practice, which is better known abroad than in France, regularly returns to the forefront of the media   Are the children born from this IVF, with genetic contributions from two women and one man, not GMOs?